Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Publication Date timeline is not available.
Page 1
Targeting β2-Adrenergic Receptors Shows Therapeutical Benefits in Clear Cell Renal Cell Carcinoma from Von Hippel-Lindau Disease.
J Clin Med. 2020 Aug 25;9(9):2740. doi: 10.3390/jcm9092740.
J Clin Med. 2020.
PMID: 32854260
Free PMC article.
The β2-adrenergic receptor antagonist ICI-118,551 blocks the constitutively activated HIF signalling in hemangioblastomas from von Hippel-Lindau disease.
Cuesta AM, Albiñana V, Gallardo-Vara E, Recio-Poveda L, de Rojas-P I, de Las Heras KVG, Aguirre DT, Botella LM.
Cuesta AM, et al. Among authors: de rojas p i.
Sci Rep. 2019 Jul 11;9(1):10062. doi: 10.1038/s41598-019-46448-6.
Sci Rep. 2019.
PMID: 31296894
Free PMC article.
Item in Clipboard
The Endothelial Landscape and Its Role in Von Hippel-Lindau Disease.
de Rojas-P I, Albiñana V, Taranets L, Recio-Poveda L, Cuesta AM, Popov N, Kronenberger T, Botella LM.
de Rojas-P I, et al.
Cells. 2021 Sep 4;10(9):2313. doi: 10.3390/cells10092313.
Cells. 2021.
PMID: 34571962
Free PMC article.
Item in Clipboard
CLN5 in heterozygosis may protect against the development of tumors in a VHL patient.
de Rojas-P I, Albiñana V, Recio-Poveda L, Rodriguez-Rufián A, Cuesta ÁM, Botella LM.
de Rojas-P I, et al.
Orphanet J Rare Dis. 2020 Jun 2;15(1):132. doi: 10.1186/s13023-020-01410-y.
Orphanet J Rare Dis. 2020.
PMID: 32487141
Free PMC article.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.